Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA‐seq analysis with RT‐qPCR validation

5 May 2020

Abstract excerpt

INTRODUCTION: Intravenous leiomyomatosis (IVL) is currently regarded as a special variant of the common uterine leiomyoma (LM). Though IVL shows a similar histological morphology to LM, IVL is characterized by unique intravenous growth patterns and low-grade malignant potential, which are quite different from LM. There are currently few studies underlying the molecular alterations of IVL, though this information...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Tumor Research and Treatment
Share to Soft tissue tumors and treatment
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32372565
DOI: 10.1002/cam4.3098

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA‐seq analysis with RT‐qPCR validationPMID 32372565Read ↗

MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.Semantic proximity Read ↗

Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Semantic proximity Read ↗

Integrated analysis reveals candidate mRNA and their potential roles in uterine leiomyomas.Semantic proximity Read ↗

Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic SubtypesSemantic proximity Read ↗

Intravenous leiomyomatosis: molecular analysis of 17 cases.Semantic proximity Read ↗

[Clinicopathological features and gene phenotypes of benign metastasizing leiomyoma].Semantic proximity Read ↗

Multidimensional Single-Cell Transcriptomic Profiling of Uterine Leiomyosarcomas Reveals Distinct Tumor States with Inferred Therapeutic VulnerabilitiesSemantic proximity Read ↗

MiR-142-3p could serve as a potential biomarker for individualized treatment of solitary and multiple leiomyomasSemantic proximity Read ↗

Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.Semantic proximity Read ↗

Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine SarcomasSemantic proximity Read ↗

A Deep Multi-Omics Integration Approach Reveals New Molecular Features of Uterine LeiomyosarcomaSemantic proximity Read ↗

Identification of Differentially Expressed mRNAs and lncRNAs in Uterine Leiomyomas with RNA SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.